Medicare Program; Meeting of the Medicare Coverage Advisory Committee-August 30, 2006, 36120-36121 [E6-9480]

Download as PDF 36120 Federal Register / Vol. 71, No. 121 / Friday, June 23, 2006 / Notices Persons wishing to attend this meeting, which is located on Federal property, must e-mail the Panel DFO to register in advance no later than 5 p.m. (e.d.t.), Wednesday, August 9, 2006. A confirmation will be sent to the requester(s) via return e-mail. The following information must be emailed or telephoned to the DFO by the date and time above: • Name(s) of attendee(s), • Title(s), • Organization, • E-mail address(es), and • Telephone number(s). VIII. Security, Building, and Parking Guidelines IX. Special Accommodations jlentini on PROD1PC65 with NOTICES Individuals requiring sign-language interpretation or other special accommodations must send a request for these services to the DFO by 5 p.m. (e.d.t.), Wednesday, August 9, 2006. Authority: Section 1833(t)(9) of the Act (42 U.S.C. 13951(t)). The Panel is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2). (Catalog of Federal Domestic Assistance Program No. 93.773, Medicare-Hospital Insurance; and Program No. 93.774, Medicare-Supplementary Medical Insurance Program). 17:22 Jun 22, 2006 Jkt 208001 BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3170–N] Medicare Program; Meeting of the Medicare Coverage Advisory Committee—August 30, 2006 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: Persons attending the meeting must present photographic identification to the Federal Protective Service or Guard Service personnel before they will be allowed to enter the building. Security measures will include inspection of vehicles, inside and out, at the entrance to the grounds. In addition, all persons entering the building must pass through a metal detector. All items brought to CMS, including personal items such as desktops, cell phones, palm pilots, etc., are subject to physical inspection. Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. (Note: Presenters must also be registered for attendance at the meeting.) The public may enter the building 30–45 minutes before the meeting convenes each day. (The meeting on Wednesday, August 23, 2006, convenes at 1 p.m.) All visitors must be escorted in areas other than the lower and first-floor levels in the Central Building. Parking permits and instructions are issued upon arrival by the guards at the main entrance. VerDate Aug<31>2005 Dated: June 16, 2006. Mark B. McClellan, Administrator, Centers for Medicare & Medicaid Services. [FR Doc. E6–9905 Filed 6–22–06; 8:45 am] SUMMARY: This notice announces a public meeting of the Medicare Coverage Advisory Committee (MCAC) (‘‘Committee’’). Among other things, the Committee provides advice and recommendations about whether scientific evidence is adequate to determine whether certain medical items and services are reasonable and necessary under the Medicare statute. This meeting will discuss the following issues: (1) Glycemic control and the use of glucose monitors by which sensors automatically monitor glucose levels in body fluids; and (2) whether and how the frequency of outpatient glucose monitoring is related to glycemic control and clinical outcomes in the various Medicare populations. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)). DATES: The public meeting will be held on Wednesday, August 30, 2006 from 7:30 a.m. until 4:30 p.m., e.s.t. Deadlines: Deadline for Presentations and Comments: Send written comments and presentations to the address listed in the ADDRESSES section of this notice by 5 p.m., e.s.t. on July 31, 2006. [Please note that the presentation you submit will be final, as no further changes to the presentation can be accepted after submission.] Deadline for Meeting Registration: For security reasons, individuals wishing to attend this meeting must register by 5 p.m., e.s.t. on August 24, 2006. Special Accommodations: Persons attending the meeting who are hearing or visually impaired, or have a condition that requires special assistance or accommodations, are asked to notify the Executive Secretary (see FOR FURTHER INFORMATION CONTACT) by August 24, 2006. PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 Meeting Location: The meeting will be held in the main auditorium of the Centers for Medicare & Medicaid Services, 7500 Security Blvd., Baltimore, MD 21244. Registration: Register by contacting Maria Ellis (410–786–0309; Maria.Ellis@cms.hhs.gov; Centers for Medicare & Medicaid Services, OCSQ— Coverage and Analysis Group, C1–09– 06, 7500 Security Boulevard, Baltimore, MD 21244). Presentation and Comment Submission: Submit presentation and comments to Michelle Atkinson, Centers for Medicare & Medicaid Services, OCSQ—Coverage and Analysis Group, C1–09–06, 7500 Security Boulevard, Baltimore, MD 21244. Web Site: You may access up-to-date information on this meeting at https:// www.cms.hhs.gov/FACA/ 02_MCAC.asp#TopOfPage. Presentations And Comments: Interested persons may present data, information, or views orally or in writing on issues pending before the Committee. Please submit written comments and presentations to the Executive Secretary at the address listed in the ADDRESSES section of this notice. FOR FURTHER INFORMATION CONTACT: Michelle Atkinson, Executive Secretary for MCAC, (410–786–2881; Michelle.Atkinson@cms.hhs.gov; Centers for Medicare & Medicaid Services, OCSQ—Coverage and Analysis Group, C1–09–06, 7500 Security Boulevard, Baltimore, MD 21244). SUPPLEMENTARY INFORMATION: ADDRESSES: I. Meeting Topic On December 14, 1998, we published a notice in the Federal Register (63 FR 68780) to describe the Medicare Coverage Advisory Committee (MCAC), which provides advice and recommendations to CMS about clinical issues. This notice announces the August 30, 2006 public meeting of the Committee. During this meeting, the Committee will discuss evidence and hear presentations and public comments concerning outpatient glycemic control (as measured by glycated hemoglobin), the frequency of glucose monitoring, and clinical outcomes in the Medicare populations. Specifically, the Committee will review the available data on the ability of glycemic control to blunt the progression of disease, reverse diabetic complications, and alter morbidity and mortality in the Medicare populations; whether the effects of glycemic control (if any) are linear and mitigated by increased hypoglycemic risk; and whether the frequency of E:\FR\FM\23JNN1.SGM 23JNN1 Federal Register / Vol. 71, No. 121 / Friday, June 23, 2006 / Notices outpatient glucose monitoring is a determinant of glycemic control and clinical outcomes in the Medicare populations. The role of variables such as the type of diabetes, the therapeutic regimen employed, the age of hyperglycemic onset, the duration of diabetes, the duration of poor glycemic control, the level of hyperglycemia, and concomitant disease will be discussed. The impediments to glucose monitoring and use of monitoring data will be considered. In addition to evaluating the available data, the Committee will identify areas in which the current data are deficient and in which additional research is warranted. Background information about this topic, including panel materials, is available on the Internet at https:// www.cms.hhs.gov/coverage/. jlentini on PROD1PC65 with NOTICES II. Meeting Procedures This meeting is open to the public. The Committee will hear oral presentations from the public for approximately 45 minutes. The Committee may limit the number and duration of oral presentations to the time available. If you wish to make formal presentations, you must notify the Executive Secretary (see FOR FURTHER INFORMATION CONTACT) and submit the following to the address listed in the ADDRESSES section of this notice by the date listed in the Deadlines section of this notice: (1) A brief statement of the general nature of the evidence or arguments you wish to present; (2) the names and addresses of proposed participants; and (3) a written copy of your presentation. Your presentation should consider the questions we have posed to the Committee and focus on the issues specific to the topic. The questions will be available on the following Web site: https://www.cms.hhs.gov/FACA/ 02_MCAC.asp#TopOfPage. We require that you declare at the meeting whether you have any financial involvement with manufacturers of any items or services being discussed (or with their competitors). After the public and CMS presentations, the Committee will deliberate openly on the topic. Interested persons may observe the deliberations, but the Committee will not hear further comments during this time except at the request of the chairperson. The Committee will also allow a 15 minute unscheduled open public session for any attendee to address issues specific to the topic. At the conclusion of the day, the members will vote and the Committee will make its recommendation. VerDate Aug<31>2005 17:22 Jun 22, 2006 Jkt 208001 III. Registration Instructions The Coverage and Analysis Group is coordinating meeting registration. While there is no registration fee, individuals must register to attend. Register by contacting Maria Ellis at the address listed in the ADDRESSES section of this notice. Please provide your name, address, organization, telephone and fax numbers, and e-mail address. You will receive a registration confirmation with instructions for your arrival at the CMS complex. You will be notified if the seating capacity has been reached. This meeting is located on Federal property; therefore, for security reasons, any individuals wishing to attend this meeting must register by 5 p.m. e.s.t. on August 24, 2006. IV. Security, Building, and Parking Guidelines This meeting will be held in a Federal government building; therefore, Federal security measures are applicable. In planning your arrival time, we recommend allowing additional time to clear security. In order to gain access to the building and grounds, individuals must present photographic identification to the Federal Protective Service or Guard Service personnel before being allowed entrance. Security measures also include inspection of vehicles, inside and out, at the entrance to the grounds. In addition, all individuals entering the building must pass through a metal detector. All items brought to CMS, whether personal or for the purpose of demonstration or to support a demonstration, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, setup, safety, or timely arrival of any personal belongings or items used for demonstration or to support a demonstration. Parking permits and instructions will be issued upon arrival. Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 30 to 45 minutes prior to the convening of the meeting. All visitors must be escorted in areas other than the lower and first floor levels in the Central Building. Authority: 5 U.S.C. App. 2, section 10(a). (Catalog of Federal Domestic Assistance Program No. 93.774, Medicare— Supplementary Medical Insurance Program) PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 36121 Dated: June 7, 2006. Barry M. Straube, Chief Medical Officer and Director, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services. [FR Doc. E6–9480 Filed 6–22–06; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2004N–0226] Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 015 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing a publication containing modifications the agency is making to the list of standards FDA recognizes for use in premarket reviews (FDA recognized consensus standards). This publication, entitled ‘‘Modifications to the List of Recognized Standards, Recognition List Number: 015’’ (Recognition List Number: 015), will assist manufacturers who elect to declare conformity with consensus standards to meet certain requirements for medical devices. DATES: Submit written or electronic comments concerning this document at any time. See section VII of this document for the effective date of the recognition of standards announced in this document. ADDRESSES: Submit written requests for single copies of ‘‘Modifications to the List of Recognized Standards, Recognition List Number: 015’’ to the Division of Small Manufacturers, International and Consumer Assistance, Center for Devices and Radiological Health (HFZ–220), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850. Send two selfaddressed adhesive labels to assist that office in processing your requests, or fax your request to 301–443–8818. Submit written comments concerning this document, or recommendations for additional standards for recognition, to the contact person (see FOR FURTHER INFORMATION CONTACT). Submit electronic comments by e-mail: standards@cdrh.fda.gov. This document may also be accessed on FDA’s Internet site at https://www.fda.gov/cdrh/ fedregin.html. See section VI of this document for electronic access to the E:\FR\FM\23JNN1.SGM 23JNN1

Agencies

[Federal Register Volume 71, Number 121 (Friday, June 23, 2006)]
[Notices]
[Pages 36120-36121]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9480]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-3170-N]


Medicare Program; Meeting of the Medicare Coverage Advisory 
Committee--August 30, 2006

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces a public meeting of the Medicare 
Coverage Advisory Committee (MCAC) (``Committee''). Among other things, 
the Committee provides advice and recommendations about whether 
scientific evidence is adequate to determine whether certain medical 
items and services are reasonable and necessary under the Medicare 
statute. This meeting will discuss the following issues: (1) Glycemic 
control and the use of glucose monitors by which sensors automatically 
monitor glucose levels in body fluids; and (2) whether and how the 
frequency of outpatient glucose monitoring is related to glycemic 
control and clinical outcomes in the various Medicare populations.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. App. 2, section 10(a)).

DATES: The public meeting will be held on Wednesday, August 30, 2006 
from 7:30 a.m. until 4:30 p.m., e.s.t.
    Deadlines: Deadline for Presentations and Comments: Send written 
comments and presentations to the address listed in the ADDRESSES 
section of this notice by 5 p.m., e.s.t. on July 31, 2006. [Please note 
that the presentation you submit will be final, as no further changes 
to the presentation can be accepted after submission.]
    Deadline for Meeting Registration: For security reasons, 
individuals wishing to attend this meeting must register by 5 p.m., 
e.s.t. on August 24, 2006.
    Special Accommodations: Persons attending the meeting who are 
hearing or visually impaired, or have a condition that requires special 
assistance or accommodations, are asked to notify the Executive 
Secretary (see FOR FURTHER INFORMATION CONTACT) by August 24, 2006.

ADDRESSES: Meeting Location: The meeting will be held in the main 
auditorium of the Centers for Medicare & Medicaid Services, 7500 
Security Blvd., Baltimore, MD 21244.
    Registration: Register by contacting Maria Ellis (410-786-0309; 
Maria.Ellis@cms.hhs.gov; Centers for Medicare & Medicaid Services, 
OCSQ--Coverage and Analysis Group, C1-09-06, 7500 Security Boulevard, 
Baltimore, MD 21244).
    Presentation and Comment Submission: Submit presentation and 
comments to Michelle Atkinson, Centers for Medicare & Medicaid 
Services, OCSQ--Coverage and Analysis Group, C1-09-06, 7500 Security 
Boulevard, Baltimore, MD 21244.
    Web Site: You may access up-to-date information on this meeting at 
https://www.cms.hhs.gov/FACA/02_MCAC.asp#TopOfPage.
    Presentations And Comments: Interested persons may present data, 
information, or views orally or in writing on issues pending before the 
Committee. Please submit written comments and presentations to the 
Executive Secretary at the address listed in the ADDRESSES section of 
this notice.

FOR FURTHER INFORMATION CONTACT: Michelle Atkinson, Executive Secretary 
for MCAC, (410-786-2881; Michelle.Atkinson@cms.hhs.gov; Centers for 
Medicare & Medicaid Services, OCSQ--Coverage and Analysis Group, C1-09-
06, 7500 Security Boulevard, Baltimore, MD 21244).

SUPPLEMENTARY INFORMATION:

I. Meeting Topic

    On December 14, 1998, we published a notice in the Federal Register 
(63 FR 68780) to describe the Medicare Coverage Advisory Committee 
(MCAC), which provides advice and recommendations to CMS about clinical 
issues.
    This notice announces the August 30, 2006 public meeting of the 
Committee. During this meeting, the Committee will discuss evidence and 
hear presentations and public comments concerning outpatient glycemic 
control (as measured by glycated hemoglobin), the frequency of glucose 
monitoring, and clinical outcomes in the Medicare populations. 
Specifically, the Committee will review the available data on the 
ability of glycemic control to blunt the progression of disease, 
reverse diabetic complications, and alter morbidity and mortality in 
the Medicare populations; whether the effects of glycemic control (if 
any) are linear and mitigated by increased hypoglycemic risk; and 
whether the frequency of

[[Page 36121]]

outpatient glucose monitoring is a determinant of glycemic control and 
clinical outcomes in the Medicare populations. The role of variables 
such as the type of diabetes, the therapeutic regimen employed, the age 
of hyperglycemic onset, the duration of diabetes, the duration of poor 
glycemic control, the level of hyperglycemia, and concomitant disease 
will be discussed. The impediments to glucose monitoring and use of 
monitoring data will be considered. In addition to evaluating the 
available data, the Committee will identify areas in which the current 
data are deficient and in which additional research is warranted.
    Background information about this topic, including panel materials, 
is available on the Internet at https://www.cms.hhs.gov/coverage/.

II. Meeting Procedures

    This meeting is open to the public. The Committee will hear oral 
presentations from the public for approximately 45 minutes. The 
Committee may limit the number and duration of oral presentations to 
the time available. If you wish to make formal presentations, you must 
notify the Executive Secretary (see FOR FURTHER INFORMATION CONTACT) 
and submit the following to the address listed in the ADDRESSES section 
of this notice by the date listed in the Deadlines section of this 
notice: (1) A brief statement of the general nature of the evidence or 
arguments you wish to present; (2) the names and addresses of proposed 
participants; and (3) a written copy of your presentation. Your 
presentation should consider the questions we have posed to the 
Committee and focus on the issues specific to the topic. The questions 
will be available on the following Web site: https://www.cms.hhs.gov/
FACA/02_MCAC.asp#TopOfPage. We require that you declare at the meeting 
whether you have any financial involvement with manufacturers of any 
items or services being discussed (or with their competitors).
    After the public and CMS presentations, the Committee will 
deliberate openly on the topic. Interested persons may observe the 
deliberations, but the Committee will not hear further comments during 
this time except at the request of the chairperson. The Committee will 
also allow a 15 minute unscheduled open public session for any attendee 
to address issues specific to the topic. At the conclusion of the day, 
the members will vote and the Committee will make its recommendation.

III. Registration Instructions

    The Coverage and Analysis Group is coordinating meeting 
registration. While there is no registration fee, individuals must 
register to attend. Register by contacting Maria Ellis at the address 
listed in the ADDRESSES section of this notice. Please provide your 
name, address, organization, telephone and fax numbers, and e-mail 
address.
    You will receive a registration confirmation with instructions for 
your arrival at the CMS complex. You will be notified if the seating 
capacity has been reached.
    This meeting is located on Federal property; therefore, for 
security reasons, any individuals wishing to attend this meeting must 
register by 5 p.m. e.s.t. on August 24, 2006.

IV. Security, Building, and Parking Guidelines

    This meeting will be held in a Federal government building; 
therefore, Federal security measures are applicable. In planning your 
arrival time, we recommend allowing additional time to clear security.
    In order to gain access to the building and grounds, individuals 
must present photographic identification to the Federal Protective 
Service or Guard Service personnel before being allowed entrance.
    Security measures also include inspection of vehicles, inside and 
out, at the entrance to the grounds. In addition, all individuals 
entering the building must pass through a metal detector. All items 
brought to CMS, whether personal or for the purpose of demonstration or 
to support a demonstration, are subject to inspection. We cannot assume 
responsibility for coordinating the receipt, transfer, transport, 
storage, set-up, safety, or timely arrival of any personal belongings 
or items used for demonstration or to support a demonstration.
    Parking permits and instructions will be issued upon arrival.


    Note: Individuals who are not registered in advance will not be 
permitted to enter the building and will be unable to attend the 
meeting. The public may not enter the building earlier than 30 to 45 
minutes prior to the convening of the meeting.


    All visitors must be escorted in areas other than the lower and 
first floor levels in the Central Building.

    Authority: 5 U.S.C. App. 2, section 10(a).

(Catalog of Federal Domestic Assistance Program No. 93.774, 
Medicare--Supplementary Medical Insurance Program)

    Dated: June 7, 2006.
Barry M. Straube,
Chief Medical Officer and Director, Office of Clinical Standards and 
Quality, Centers for Medicare & Medicaid Services.
[FR Doc. E6-9480 Filed 6-22-06; 8:45 am]
BILLING CODE 4120-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.